Welcome to
On Feet Nation
gopalsingh2000 Online
Rowan Campbell Online
Shiela Online
Jack Miller Online
Susan Online
Robert Online
goditac499 Online
Rebecca Online
Amy Online
Posted by gopalsingh2000 on August 13, 2024 at 1:15pm 0 Comments 0 Likes
Posted by Rowan Campbell on August 13, 2024 at 1:15pm 0 Comments 0 Likes
Upon realizing the potential of this novel target, industry stakeholders have initiated several R&D efforts focused on exploiting the use of CD-47 as an effective biomarker for the diagnosis and treatment purposes
Roots Analysis is pleased to announce the publication of its recent study, titled, “CD-47 Targeting Therapeutics Market, 2021-2035.”
The report features an extensive study of the current landscape, offering an informed opinion on the likely adoption of CD47 targeting therapeutics in the healthcare industry, over the next 15 years. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:
A detailed assessment of the current market landscape of drug developers engaged in the development of CD-47 targeting therapeutics market.
Detailed profiles of developers of CD-47 targeting therapeutics developers (shortlisted on the basis of our proprietary scoring criteria).
A detailed analysis of more than 70 completed, ongoing and planned clinical studies of CD-47 targeting therapeutics domain.
A detailed review of close to 600 peer-reviewed, scientific articles related to research on CD47 targeting therapies.
An analysis of the partnerships that have been established in this domain, in the recent past.
An analysis of the funding and investments that have been carried out in this domain, in the recent past.
An analysis highlighting the key opinion leaders (KOLs) in this domain.
An analysis highlighting various social media trends (Facebook).
A competitiveness analysis of companies, featuring insightful pictorial summaries and representations.
An analysis of the initiatives of big biopharma players engaged in this domain.
An analysis of the various start-ups engaged in this domain.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Target Disease Indication
Acute Myeloid Leukemias
Non-Hodgkin Lymphoma
Colorectal Cancers
Diffuse Large B-Cell Lymphoma
Myelodysplastic Syndromes
Non-Small Cell Lung Cancers
Ovarian Epithelial Cancer
Oral Muscositis
Small Cell Lung Cancers
Type of Molecule
Biologics
Small Molecules
Key Geographical Region
US
France
Germany
Italy
Spain
UK
Australia
China
India
Israel
Key companies covered in the report
ALX Oncology
Conjupro Biotherapeutics
EpicentRx
Forty Seven
Innovent Biologics
KAHR Medical
Trillium Therapeutics
For more information please click on the following link:
https://www.rootsanalysis.com/reports/cd-47-targeting-therapeutics-...
You may also be interested in the following titles:
1. RAS Targeting Therapies Market, 2021-2031
2. Squamous NSCLC Market, 2021-2031
3. Peptide Therapeutics Market, 2021-2031
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]
Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
[email protected]
© 2024 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation